Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies.

Transfusion

Volumn 42, Issue 2, 2002, Pages 139-145

  Purmal, Andrei ^a   Valeri, C Robert ^a   Dzik, Walter ^a   Pivacek, Linda ^a   Ragno, Gina ^a   Lazo, Aris ^a   Chapman, John ^a  

^a VI Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; AZIRIDINE; AZIRIDINE DERIVATIVE; MEMBRANE ANTIGEN; PEN 110; POLYAMINE; POTASSIUM;

ANIMAL; ARTICLE; BLOOD; BLOOD DONOR; BOVINE DIARRHEA VIRUS; CHEMISTRY; DISEASE TRANSMISSION; DISINFECTION; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; HEMOLYSIS; HUMAN; IMMUNOLOGY; KINETICS; PAPIO; PORCINE PARVOVIRUS; VIROLOGY; VIRUS INFECTION;

2,3-DIPHOSPHOGLYCERATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, SURFACE; AZIRIDINES; BLOOD DONORS; DIARRHEA VIRUSES, BOVINE VIRAL; DISINFECTION; ERYTHROCYTE AGING; ERYTHROCYTES; HEMOLYSIS; HUMANS; KINETICS; PAPIO; PARVOVIRUS, PORCINE; POLYAMINES; POTASSIUM; VIRUS DISEASES;

EID: 0036480485     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00020.x     Document Type: Article

References (0)